Although non-cancerous, uterine fibroids can cause many women concern. These tumors grow in and on the womb, and while many ...

Gynesonics’ transcervical system uses ultrasound guidance and radiofrequency energy to ablate fibroids without the need for ...

Hologic Inc. is acquiring Gynesonics for $350 million, adding the Sonata System to its fibroid treatment lineup. The ...

An enlarged uterus is a condition where the uterus becomes larger than its normal size often due to underlying health issues ...

Hologic has signed a definitive agreement for the acquisition of Gynesonics, which develops minimally invasive solutions for ...

The following is a summary of "Management of Uterine Fibroids and Sarcomas: The Palermo Position Paper," published in the ...

Hysterectomy, a surgical procedure to remove the uterus, is a topic that can stir many emotions and concerns. For women ...

Hologic this week announced it signed a definitive agreement to acquire Gynesonics for approximately $350 million.

Millions of women get fibroid treatments each year. One in every 3 women who menstruate develop fibroids in their lifetime. Fibroids are common in women who menstruate, and they cause abnormal ...

Medical device manufacturer Hologic is broadening its focus on women’s health as the Marlborough-based firm has signed a ...

Gynesonics pioneered and launched the Sonata System, the first FDA-cleared medical device for diagnostic intrauterine imaging ...